rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2006-1-9
|
pubmed:abstractText |
Because low plasma glutamate and glutamine concentrations are often seen in chronic obstructive pulmonary disease (COPD), glutamine or glutamate supplementation may be a good option for preventing further metabolic disturbances in COPD patients. However, the metabolic effects of glutamate supplementation have never been compared with those of glutamine supplementation.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0002-9165
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
83
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
115-23
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16400059-Aged,
pubmed-meshheading:16400059-Amino Acids,
pubmed-meshheading:16400059-Case-Control Studies,
pubmed-meshheading:16400059-Deuterium,
pubmed-meshheading:16400059-Dietary Supplements,
pubmed-meshheading:16400059-Glutamic Acid,
pubmed-meshheading:16400059-Glutamine,
pubmed-meshheading:16400059-Health Status,
pubmed-meshheading:16400059-Humans,
pubmed-meshheading:16400059-Male,
pubmed-meshheading:16400059-Middle Aged,
pubmed-meshheading:16400059-Muscle, Skeletal,
pubmed-meshheading:16400059-Postprandial Period,
pubmed-meshheading:16400059-Pulmonary Disease, Chronic Obstructive,
pubmed-meshheading:16400059-Respiratory Function Tests
|
pubmed:year |
2006
|
pubmed:articleTitle |
Metabolic effects of glutamine and glutamate ingestion in healthy subjects and in persons with chronic obstructive pulmonary disease.
|
pubmed:affiliation |
Department of Respiratory Medicine, University of Maastricht, Maastricht, The Netherlands. e.rutten@pul.unimaas.nl
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|